Conferences Prelude Therapeutics is attending in 2026

preludetx.com

Prelude Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026: TPD Summit 2026 (on the program) and Discovery on Target 2026 (on the program). Prelude Therapeutics is a small-molecule drug discovery company developing targeted therapies for cancer. As of Oct 17, 2026.

ConferenceDetailsInvolvementTnuki guide
9th TPD & Induced Proximity SummitTargeted protein degradation scientistsOfficial site
Boston, MA ~300 attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 1 talk
Attending
  • Sr. Director
Attendee mix: Almost entirely industry; degrader discovery chemists, biologists and biotech executives
Open the guide Search and filter attendees
Discovery on Target 2026Target discovery biologists & chemistsOfficial site
Past Boston, MA ~1.1k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 1 roundtable discussion, 1 talk
Attending
  • Associate Director
Attendee mix: Mostly biopharma; target discovery biologists, medicinal chemists and discovery group leaders, some academics
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Prelude Therapeutics’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Prelude Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →